Kailun Fei

4PUBLICATIONS
41CO-AUTHORS
Molecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Mar 12, 2026
Aumolertinib with carboplatin-pemetrexed versus aumolertinib for nonsmall cell lung cancer with EGFR and concomitant tumor suppressor genes (ACROSS2): An open-label, multicenter, randomized phase 3 study.

Jian-Chun Duan, Jia Zhong, Bo-Yang Sun

|Oct 04, 2023
Development and validation of a nomogram based on preoperative variables for predicting recurrence-free survival in stage IA lung adenocarcinoma.

Jiaxi Xu, Hui Zeng, Guochao Zhang

|May 24, 2023
Abnormal activation of NF-κB and MAPK signaling pathways affect osimertinib resistance and influence the recruitment of myeloid-derived suppressor cells to shape the immunosuppressive tumor immune microenvironment.

Chao Wang, Kailun Fei, Lihui Liu

|Jun 17, 2021
Weighting tumor-specific TCR repertoires as a classifier to stratify the immunotherapy delivery in non-small cell lung cancers.

Jiefei Han, Ruofei Yu, Jianchun Duan

Pageof 1

Frequent Collaborators

3 joint publications

Jie Wang

2 joint publications

Jianchun Duan

2 joint publications

Jiachen Xu

2 joint publications

Zhijie Wang